Detalhe da pesquisa
1.
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy.
Blood
; 121(2): 278-85, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23149845
2.
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
Br J Haematol
; 141(6): 840-7, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18371107
3.
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study.
J Clin Oncol
; 30(4): 387-93, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22215753
4.
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Blood
; 109(7): 2773-80, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17132719
5.
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.
Blood
; 109(7): 2736-43, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17138821
6.
Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical quality.
J Pediatr Hematol Oncol
; 28(9): 568-74, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17006262